The Market Fieldbook

Confirming your account

Your account is being prepared. You will be redirected securely in a moment.

The Market Fieldbook

Company Observatory

HRMY

Harmony Biosciences Holdings, Inc.

Healthcare · Biotechnology

Overall research band Strong
Quality Strong
Valuation Weak
Balance sheet Strong
Market confirmation Exceptional

One-minute company read

What this report can tell you now

What the company does

Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company based in Plymouth Meeting, Pennsylvania, focused on developing and marketing therapies for individuals in the United States with rare neurological conditions. Its main product is WAKIX, a prescription medication indicated for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company generates revenue by selling its pharmaceutical products to healthcare providers and patients affected by these rare neurological disorders.

The current research profile is Growth at a Reasonable Price, with strong market confirmation. This is a starting point for investigation, not a forecast or recommendation.

Strongest visible signal

Recent market behavior is the strongest visible confirmation. Check whether it agrees with the underlying business evidence.

What to investigate next

Read the latest filing or company update, check the period behind the metrics, and investigate the dimension with the weakest band above.

Before you draw a conclusion

  • Read the latest filing or company update.
  • Check the financial period behind each metric.
  • Investigate the weakest score band and any missing evidence.

Headline fundamentals

A small set of signals worth checking

ROIC41.3%Model input; read with the evidence status and period context.
Operating margin24.0%Model input; read with the evidence status and period context.
Revenue CAGR · 4 years29.9%Model input; read with the evidence status and period context.
FCF margin40.1%Model input; read with the evidence status and period context.

Go deeper when you need to

Compare the right companies, understand what changed, and monitor the evidence.

Peer contextCompare companies using the appropriate economic neighborhood.
Evidence detailSee exact inputs, source context, and model-aware metrics.
HistoryReview score and research changes over time.
MonitoringKeep the questions, risks, and changes that matter in view.

The public report remains useful on its own. Premium adds depth, history, comparison, and monitoring.